ArticleJournal of translational medicine2025

GPX2 inhibition enhances antitumor efficacy of lenvatinib via promoting immunogenic cell death in hepatocellular carcinoma.

Yingzheng Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.